Shahrokh Shariat, Professor and Chairman of the Department of Urology, Director of the Comprehensive Cancer Center shared on LinkedIn:
“Austria has been testing men for prostate cancer for more than 30 years – without an organised national early detection programme.
The consequences: unequal access, unnecessary examinations, overdiagnosis and overtreatment. At the same time, quality and results are hardly systematically recorded.
We can do better. Organized, risk-adapted early detection combines clear criteria for age and life expectancy with PSA-based risk assessment, MRI before a biopsy, targeted biopsy if indicated and active monitoring for low-risk prostate cancer.
The goal: to reduce mortality from prostate cancer and minimize possible damage.
Austria’s participation in PRAISE-U Plus and our national consensus process with 65 experts from 22 organisations create a viable basis for change.
The health policy question is clear: Do we continue unstructured testing or do we establish an organised, quality-assured programme that is accessible to all?
Men in Austria and their families deserve action now.
You can also read: 10 Prostate Cancer Trials to Watch at ESMO 2026
